The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Rheumatology

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 12233878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?

  2001cited by this paper
• Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study

  2001cited by this paper
• Premature mortality in patients with rheumatoid arthritis: evolving concepts.

  2001cited by this paper
• No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

  2000cited by this paper
• Recent onset arthritis in the elderly: a 5 year longitudinal observational study.

  2000cited by this paper
• Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992.

  2000cited by this paper
• Reporting requirements for longitudinal observational studies in rheumatology.

  1999cited by this paper
• Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.

  1999cited by this paper
• Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?

  1999cited by this paper
• Critical issues in longitudinal and observational studies: purpose, short versus long term, selection of study instruments, methods, outcomes, and biases.

  1999cited by this paper
• Longitudinal and observational studies module.

  1999cited by this paper
• Mortality in rheumatoid arthritis patients with disease onset in the 1980s

  1999cited by this paper
• Mortality in rheumatoid arthritis: have we made an impact in 4 decades?

  1999cited by this paper
• Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years.

  1997cited by this paper
• Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings.

  1996cited by this paper
• Mortality in rheumatoid arthritis: do age and gender make a difference?

  1996cited by this paper
• Mortality in rheumatoid arthritis.

  1995cited by this paper
• Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology.

  1993cited by this paper
• Minimum important difference between patients with rheumatoid arthritis: the patient's perspective.

  1993cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices.

  1985cited by this paper

• 2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs

  2024cites this paper
• Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort

  2022influential citation
• Geriatric Syndromes among Patients with Rheumatoid Arthritis: A Comparison between Young and Elderly Patients

  2022cites this paper
• Male Sex Predicts a Favorable Outcome in Early ACPA-Negative Rheumatoid Arthritis: Data From an Observational Study

  2022cites this paper
• Muscle mass loss is associated with physical dysfunction in patients with early rheumatoid arthritis

  2022cites this paper
• The assessment of the quality of life in patients with rheumatoid foot.

  2022cites this paper
• Is pain associated with premature mortality in patients with psoriatic arthritis? A nested case-control study using the DANBIO Register.

  2021cites this paper
• Habitual fish intake negatively correlates with prevalence of frailty among patients with rheumatoid arthritis

  2021cites this paper
• Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study

  2020influential citation
• Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

  2020cites this paper
• Health Assessment Questionnaire at One Year Predicts All‐Cause Mortality in Patients With Early Rheumatoid Arthritis

  2020cites this paper
• Mediastinal and axillar lymphadenopathy in patients with rheumatoid arthritis: prevalence and clinical significance.

  2019cites this paper
• 2019 American College of Rheumatology Recommended Patient‐Reported Functional Status Assessment Measures in Rheumatoid Arthritis

  2019cites this paper
• Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice.

  2019cites this paper
• Predictors and the optimal duration of sustained remission in rheumatoid arthritis

  2019cites this paper
• Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States

  2018cites this paper
• Clinical characteristics and prognostic factors of pneumonia in patients with and without rheumatoid arthritis

  2018cites this paper
• Immune responses to homocitrulline- and citrulline-containing peptides in rheumatoid arthritis

  2017cites this paper
• Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain

  2016cites this paper
• Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review

  2016cites this paper
• Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs

  2016cites this paper
• Patient and physician perspectives of hand function in a cohort of rheumatoid arthritis patients: the impact of disease activity

  2016cites this paper
• Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.

  2016cites this paper
• Measuring the economic value of morning stiffness: consistency over 1 year

  2016cites this paper
• The durability of abatacept as a first and subsequent biologic and improvement in HAQ from a large multi-site real-world study.

  2015cites this paper
• Current cigarette use in rheumatoid arthritis patients: associated factors and a limited mediating role of depression

  2015cites this paper
• Relationship of Meeting Physical Activity Guidelines With Health‐Related Utility

  2014cites this paper
• Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study.

  2014cites this paper
• Clinical measurement of disease activity in rheumatoid arthritis: why, how and utility of patient self-assessment

  2014cites this paper
• Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor

  2014cites this paper
• [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 14. Treat to target strategy in rheumatoid arthritis].

  2014cites this paper
• 14．Treat to Targetと関節リウマチ

  2014cites this paper
• Efficacy of biologic agents in improving the Health Assessment Questionnaire (HAQ) score in established and early rheumatoid arthritis: a meta-analysis with indirect comparisons.

  2014cites this paper
• An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression

  2013cites this paper
• The 'therapeutic window' and treating to target in rheumatoid arthritis.

  2013cites this paper
• Feminization of Disease and Disability Association in Six Low and Middle Income Countries: Evidence from the Study of Global Ageing and Health

  2013cites this paper
• Review on the Influence of Protocol Design on Clinical Outcomes in Rheumatoid Arthritis Treated with Rituximab

  2013influential citation
• Pursuit of optimal outcomes in rheumatoid arthritis

  2012cites this paper
• Hearing, mobility, and pain predict mortality: a longitudinal population-based study.

  2012cites this paper
• Epidemiology and burden of illness of rheumatoid arthritis

  2012cites this paper
• Mortality Risk by Functional Status and Health-related Quality of Life in Patients with Rheumatoid Arthritis

  2012cites this paper
• Aerobic Activity in Prevention and Symptom Control of Osteoarthritis

  2012cites this paper
• Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy

  2012cites this paper
• Economic Evaluations in Rheumatoid Arthritis

  2012cites this paper
• An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis

  2012cites this paper
• Clinical and epidemiological research

  2011cites this paper
• Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden

  2010cites this paper
• recommendations of an international task force Treating rheumatoid arthritis to target

  2010cites this paper
• The Economic Burden of Rheumatoid Arthritis: Asia/Thailand Perspective

  2010cites this paper
• The CoMorbidities and Mortality Rate among Rheumatoid Arthritis Patients at the Western Region of Saudi Arabia A Retrospective Cross-Sectional Study

  2010cites this paper
• Treating rheumatoid arthritis to target: recommendations of an international task force

  2010cites this paper
• Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE study.

  2010cites this paper
• The Number Needed to Treat to Improve Health Assessment Questionnaire Psoriatic Arthritis, and Ankylosing Spondylitis: Cost-Effectiveness Based on Real-World Anti-Tumor Necrosis Factor Treatment in Rheumatoid Arthritis,

  2009cites this paper
• Real-World Anti-Tumor Necrosis Factor Treatment in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis: Cost-Effectiveness Based on Number Needed to Treat to Improve Health Assessment Questionnaire

  2009cites this paper
• Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

  2009cites this paper
• Changes in Functional Status Among Persons Over Age Sixty-Five Undergoing Total Knee Arthroplasty

  2009cites this paper
• Developments in the clinical understanding of rheumatoid arthritis

  2009cites this paper
• The Co-Morbidities and Mortality Rate among Rheumatoid Arthritis Patients at the Western Region of Saudi Arabia A Retrospective Cross-Sectional Study

  2009cites this paper
• Cost-effectiveness of Early Use of Etanercept in the Treatment of Rheumatoid Arthritis

  2009cites this paper
• Review Developments in the clinical understanding of rheumatoid arthritis

  2009cites this paper
• Geriatric syndromes in elderly patients with rheumatoid arthritis.

  2009cites this paper
• Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists.

  2008cites this paper
• Mortality in rheumatoid arthritis: 2008 update.

  2008influential citation
• Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health States.

  2008cites this paper
• Patterns of psychosocial risk and long-term outcomes in rheumatoid arthritis

  2008cites this paper
• Arthritis disability and heart disease disability.

  2008cites this paper
• active rheumatoid arthritis based on the TEMPO trial combination with methotrexate in the treatment of Cost effectiveness of etanercept (Enbrel) in

  2007cites this paper
• Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial

  2007cites this paper
• Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate.

  2007cites this paper
• The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments

  2007cites this paper
• Artritis reumatoide: ¿cuán cara es?

  2007cites this paper
• Mortalité dans les rhumatismes inflammatoires chroniques

  2006cites this paper
• Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.

  2006cites this paper
• Social and economic impact of inflammatory arthritis.

  2006cites this paper
• A prognostic model for functional outcome in early rheumatoid arthritis.

  2006cites this paper
• Population impact of arthritis on disability in older adults.

  2006cites this paper
• Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register

  2006cites this paper
• Rheumatoid arthritis--Crohn's disease connection.

  2005cites this paper
• Utilización de recursos en una cohorte de pacientes con artritis reumatoide atendidos en área especializada de reumatología en España

  2005cites this paper
• [Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain].

  2005influential citation
• Utilización de recursos en una cohorte de pacientes con artritis reumatoide atendidos en área especializada de reumatología en España

  2005influential citation
• Practices for managing a flare of long-standing rheumatoid arthritis: survey among French rheumatologists.

  2005cites this paper
• Activity limitation in rheumatoid arthritis correlates with reduced grip force regardless of sex: the Swedish TIRA project.

  2005cites this paper
• Análisis de costes en una cohorte de enfermos con artritis reumatoide atendidos en área especializada de reumatología en España

  2005influential citation
• Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

  2005cites this paper
• Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial

  2005cites this paper
• [Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain].

  2005cites this paper
• Mortality in rheumatoid disease.

  2004cites this paper
• Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

  2004cites this paper
• Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery.

  2004cites this paper
• Impact of imaging in established rheumatoid arthritis.

  2003cites this paper
• Impact of imaging in established rheumatoid arthritis.

  2003cites this paper
• Disease activity in rheumatoid arthritis : Studies in interleukin-6, tumour necrosis factor alpha, monocyte activity, acute phase markers, glucocorticoids, and disability

  2003influential citation
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1248

  2003cites this paper